Showing 9 of 29 recruiting trials for “thyroid-lymphoma”
Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
RecruitingNCT06822855 ↗
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
👨⚕️ Luminari Stefano, MD, Azienda USL - IRCCS di Reggio Emilia📍 12 sites📅 Started Jun 2022View details ↗
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
👨⚕️ Stefano Luminari, MD, Ematologia, AUSL IRCCS Reggio Emilia📍 2 sites📅 Started Feb 2022View details ↗
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-Hodgkin
Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
👨⚕️ Alison Moskowitz, MD, Memorial Sloan Kettering Cancer Center📍 10 sites📅 Started Nov 2016View details ↗
RecruitingNCT01790152 ↗
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →